Xers
Dear $XERS friends, after my sale on December 31 last year, I decided to buy Xeris again today at 1.82.
For the following reasons: a top 10 pharma could announce at any time the exercise of the option to develop a product via Xeriject, encouraging (but not incredible) Gvoke scripts in the last few weeks, Levo Ph1-results coming soon, Q3 results soon, with certainly an acceleration of Recorlev sales, no capital increase in sight.
Now long with TFFP (60%) und XERS (40%)
@Pee, ich schaue heute Abend oder morgen.